My blog: bkoffman.blogspot.com sports the second part of the interview with Dr. Sharman, plus my discussion of predictive versus prognostic markers, and some bad news.
Dr. Sharman Part 2 of the Interview on Prognos... - CLL Support
Dr. Sharman Part 2 of the Interview on Prognostic Factors
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
4 Replies
•
AussieNeilPartnerAdministrator
Very interesting to hear what Dr Sharman considers useful tests which starts at 2:40. Seems Zap-70 has had its day.
Thanks Brian. It's frustrating hearing about these new markers while there is no testing for them at present. I asked my consultant if I was likely to get tested for BIRC3 or SF3B1 while on the RESONATE2 Imbruvica study but it seems there are no plans to.
I tend to think that if BIRC3 is as bad as p17/p53, I would know it by now if I had it after nearly 4 years with the 11q.
bkoffmanCLL CURE Hero
It is frustrating, but may be moot with the new meds. Still unclear.
Sorry to hear about the loss of your 2 friends.
Not what you're looking for?
You may also like...
Dr Jeff Sharman on Nutritional Supplements
For one of most balanced and informative postings I've read on nutritional supplements and how they...
Part 2 of ASH Interview with Dr. Sharman, a patient meeting in Seattle and off to iwCLL later tonight
Friends,
This week on the CLL Society website, in our Conference coverage section, we share the...
FCR may CURE some of us - Dr Sharman
"In today's CLL climate, web informed patients are rebelling against FCR - and in many cases, I...
Dr Sharman on "Choosing first therapy in CLL"
Dr. Sharman briefly discusses the whys of the rather unique Watch and Wait 'treatment' decision for...
ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"
Dr Sharman's blog http://www.cll-nhl.com, is well worth keeping an eye on for pertinent but easily...